Tier 3 Drug Shortages
Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:
- a review of the information gathered on the shortage issue, and
- a thorough discussion on its potential impact and next steps.
Below are the newest and most recently updated active ingredients that have been designated as Tier 3 shortages. Click on the active ingredient to see a list of the associated Tier 3 drug shortage and/or discontinuation reports.
Active Ingredient
32 active ingredients found
ACETYLCHOLINE CHLORIDE
powder for solution |
ACETYLCYSTEINE
solution |
Amiodarone Injection
liquid |
Amoxicillin and Clavulanic Acid Oral Suspensions
powder for suspension |
Amoxicillin Oral Suspensions
powder for suspension |
Amoxicillin Oral Suspensions
granules for suspension |
ASPARAGINASE - ERWINASE
powder for solution |
Azithromycin – Oral Suspension
powder for suspension |
BSS Sterile Irrigating Solution
solution |
CALCITONIN
solution |
CARBACHOL
solution |
Cefprozil – Oral Suspension
powder for suspension |
Cefuroxime – Oral Suspension
granules for suspension |
Cephalexin – Oral Suspension
powder for suspension |
Clarithromycin – Oral Suspension
granules for suspension |
DEXRAZOXANE
powder for solution |
Eluxadoline
tablet |
Eptifibatide Injection
solution |
FLUDARABINE PHOSPHATE
tablet |
HALOPERIDOL
tablet |